Amicus Therapeutics Inc (FOLD) earnings · rev $634.2M
These earnings events as JSON? API free 100/dayAmicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
This FOLD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FOLD revenue for 2025-12-31 was $634.2M. Net income was -$27.1M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. FOLD currently screens at market cap $1.80B.
When the next FOLD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 20.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FOLD research stays on the stock page; the tape stays on the quote page.
FOLD earnings FAQ
What are FOLD's latest revenue and net income?
Latest cached Amicus Therapeutics Inc (FOLD) revenue for Dec 31, 2025 was $634.2M. Net income was -$27.1M. Statements: https://lician.com/financials/fold
What is FOLD's latest diluted EPS?
Latest cached Amicus Therapeutics Inc (FOLD) diluted EPS for Dec 31, 2025 was -$0.09.
What period does the latest FOLD earnings print cover?
The latest cached Amicus Therapeutics Inc (FOLD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did FOLD revenue change from the prior cached period?
Cached Amicus Therapeutics Inc (FOLD) revenue was up 20.0% from $528.3M (Dec 31, 2024) to $634.2M (Dec 31, 2025). Statements: https://lician.com/financials/fold
Where are FOLD earnings listed?
Cached earnings facts for Amicus Therapeutics Inc (FOLD) are listed at https://lician.com/earnings/fold. Statements: https://lician.com/financials/fold
Not investment advice.